Healthcare Revolution How Technology is Transforming Medicine with Sensors 3D Printing and Wearables Bitcoin Slips Below 76000 as Iran Tensions Rise and ETF Outflows Accelerate Kevin Warsh Poised to Enter Fed Amid Internal Debate Over Interest Rate Cuts SpaceX Eyes Public Markets What Investors Should Know About the Potential IPO Kazatomprom Reports 17 Production Surge in Q3 Signaling Strong Uranium Output Elon Musk Faces Legal Setback in OpenAI Lawsuit But Expected to Maintain Aggressive Approach Aclarion Inc Q1 2026 Earnings EPS Surpasses Estimates as Company Prioritizes Cost Controls Domo Inc Q1 2026 Earnings Beats EPS Estimates by Wide Margin SnapOn Q1 2026 Earnings EPS Falls Short of Expectations Shares Edge Higher FUL Q1 2026 Earnings EPS Beats Estimates as Stock Rises 25 AWR Q1 2026 Earnings EPS Misses Estimates by 228 Stock Gains 08 MaxLinear Q1 2026 Earnings EPS Beats Estimates Despite Revenue Uncertainty CBL International Limited BANL Gains Ground Approaching Resistance at 042 CoreWeave CRWV Edges Higher as Cloud AI Infrastructure Play Holds Key Support Space Asset Acquisition Corp SAAQ Holds Steady Near Resistance as SPAC Investors Await Catalyst FibroBiologics Inc FBLG Rallies 57 as Shares Test Key Resistance at 118 Horizon Technology Finance Notes HTFC Edge Higher in Quiet Trading OIG Report Criticizes USP Canaan Prison Conditions Systemic Issues May Drive Policy Reform VIV Q1 2026 Earnings EPS Misses Estimates Stock Sheds 172 Thor Industries THO Rises 184 as RV Maker Holds Above Support Tests Key Resistance Centuri Holdings Inc CTRI Q1 2026 Earnings Narrowing Loss Beats Expectations on Cost Discipline RFIL Q1 2026 Earnings Strong EPS Beat of 96 Surprises Analysts Traws Pharma Inc TRAW Q1 2026 Earnings Narrower Net Loss Beats Estimates as Clinical Pipeline Advances DAWN Q4 2025 Earnings WiderThanExpected Loss As PreRevenue Biotech Advances Pipeline GPUS Q3 2025 Earnings Losses Persist as Hyperscale Data Ramps Up Investment AGBK Q1 2026 Earnings EPS Surpasses Estimates by 621 AMPY Q1 2026 Earnings Significant earnings miss as reported loss of 093 per share versus consensus estimate